Physician profile
Jason Nelson
NPI 1700097235
$4,267.61
in general payments reported to CMS, 2019-2025
16 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.65 · 2020: $517 · 2021: $1,244 · 2022: $964 · 2023: $673 · 2024: $427 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,443.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,534.16 | 2021-2025 | |
| Paratek Pharmaceuticals, INC. | $790.74 | 2021-2025 | Nuzyra |
| Janssen Pharmaceuticals, INC | $574.64 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $378.36 | 2019-2023 | Lokelma |
| Allergan, INC. | $326.80 | 2020 | |
| Novartis Pharmaceuticals Corporation | $151.87 | 2019-2024 | |
| Insmed, INC. | $132.89 | 2023 | Arikayce |
| La Jolla Pharmaceutical Company | $124.46 | 2022 | |
| Melinta Therapeutics, LLC | $72.14 | 2021-2024 | Rezzayo |
| Pfizer INC. | $64.24 | 2022-2024 | |
| Amgen INC. | $30.96 | 2020-2025 | Evenity |
| Vifor Pharma, INC. | $25.90 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.66 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.25 | 2019 | |
| Merck Sharp & Dohme LLC | $13.47 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.